33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A brief mind-body intervention to reduce pain and anxiety during prostate needle biopsy: A randomized, controlled trial with two-staged consent
    Meeting Abstract

    Gaffney, C.; Vertosick, E. E.; Carlsson, S. V.; Lin, X.; Wolchasty, N.; Hardbattle, R.; Vickers, A.; Ehdaie, B.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • 3D genomics identify alternate mechanisms of homologous recombination deficiency in uterine sarcoma
    Meeting Abstract

    Chiang, S.; Hensley, M. L.; Vasudevaraja, V.; Tran, I.; Yang, Y.; Stewart, C. J. R.; Park, K. J.; Ellenson, L. H.; Sikkink, K.; Schmitt, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Analysis of androgen receptor dynamics through immunofluorescent staining of circulating tumor cells in castration-resistant prostate cancer
    Meeting Abstract

    Barnett, E.; Gupta, S.; Erazo, T.; Lam, E.; Carbone, E.; Zanone, M.; Nystrom, L.; Gajar, R. N.; Wenstrup, R.; Scher, H. I.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1/2 study of bay 18953444 (elimusertib) in pediatric patients with relapsed or refractory solid tumors: Initial report of the phase 1 results of PEPN2112
    Meeting Abstract

    Ortiz, M. V.; Glade Bender, J. L.; Minard, C. G.; Liu, X.; Denic, K. Z.; Reid, J. M.; Militano, O.; Church, A. J.; Kentsis, A.; Reynolds, C. P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Oncologic outcomes in patients with radiation associated rectal adenocarcinoma
    Meeting Abstract

    Omer, D. M. R.; Verheij, F. S.; Luthra, A.; Rosen, R.; Thompson, H. M.; Romesser, P. B.; Paty, P.; Garcia-Aguilar, J.; Sanchez-Vega, F.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Negative selection of patients (pts) with HER2-positive and RAS wild-type (wt) metastatic colorectal cancer (mCRC) receiving dual HER2 blockade
    Meeting Abstract

    Randon, G.; Nakamura, Y.; Yaeger, R.; Lonardi, S.; Cremolini, C.; Elez, E.; Nichetti, F.; Ghelardi, F.; Nasca, V.; Bergamo, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Ustekinumab for the treatment of immune related cutaneous adverse events (ircAEs)
    Meeting Abstract

    Maier, T.; Gu, S.; Shah, N. J.; Faleck, D. M.; Lacouture, M. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Predictors of resistance to trastuzumab deruxtecan (T-DXd) in esophagogastric adenocarcinoma (EGC)
    Meeting Abstract

    Tsai, C.; Chou, J. F.; Biachi de Castria, T.; Tang, L. H.; Ilson, D. H.; Ku, G. Y.; Schultz, N.; Capanu, M.; Janjigian, Y. Y.; Maron, S. B.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real world treatment patterns and survival by germline BRCA (gBRCA) mutation status in patients with HER2-negative early breast cancer (eBC) in the US community oncology setting: A retrospective observational study
    Meeting Abstract

    Andersen, J. C.; Earla, J. R.; Fulcher, N.; Ndukum, J.; Robert, N. J.; Robson, M. E.; Li, W.; Mejia, J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Pooled analysis of cytokine release syndrome across cohorts in patients with advanced synovial sarcoma
    Meeting Abstract

    D'Angelo, S. P.; Ganjoo, K. N.; Blay, J. Y.; Valverde, C.; Araujo, D. M.; Abdul Razak, A. R.; Le Cesne, A.; Schuetze, S.; Wagner, M. J.; Attia, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save